PPT-PHARMACOGENETICS OF ANTIRETROVIRAL DRUGS USED FOR PREVENTION OF MOTHER-TO-CHILD TRANSMISSION

Author : jane-oiler | Published Date : 2018-12-14

PhD Viva Seminar Department of Molecular and Clinical Pharmacology University of Liverpool Adeniyi Olagunju Project History Nigerian Map Patients waiting to receive

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "PHARMACOGENETICS OF ANTIRETROVIRAL DRUGS..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

PHARMACOGENETICS OF ANTIRETROVIRAL DRUGS USED FOR PREVENTION OF MOTHER-TO-CHILD TRANSMISSION: Transcript


PhD Viva Seminar Department of Molecular and Clinical Pharmacology University of Liverpool Adeniyi Olagunju Project History Nigerian Map Patients waiting to receive a ntiretroviral drugs . Directed Readings . In the Classroom. January/February 2013 issue . of . Radiologic . Technology. Instructions:. This presentation provides a framework for educators and students to use Directed Reading content published in . CARE. Ana Carolina Maria Araújo Chagas Costa . Lima*. Karine . de Castro . Bezerra*. Deise . Maria do Nascimento . Souza*. Joanna . de Freitas . Rocha*. Mônica . Oliveira Batista . Oriá*. *. Universidade Federal do Ceará (. Shaw Vonder Hoya. Worldwide Prevalence. Types of HIV. HIV type 1:. Most common. Originated from chimpanzee SIV. High infectivity and virulence. HIV type 2:. Mostly confined to West Africa. Came from sooty . Module 10:. Pharmacovigilance. Background – definitions. Timeline of pharmacovigilance for a drug from development (pre-market) to post-marketing use. Burden of adverse drug reactions in children. Number of pharmacoepidemiological safety studies in children (Osokogu et al, 2016). Missed Opportunities. Ryan White 2012 Conference. Andrew Helfgott, MD. Robert Lawrence, MD. JoNell Potter, PhD, RN. Yvette Rivero, MPH. Workshop Facilitators. Andrew Helfgott, MD . High Risk Obstetrical Services All Children’s Hospital, FL Faculty of Florida / Caribbean AETC. HIV-Free . Survival in Swaziland: A Community-based Household Survey . Dr. Caspian Chouraya: . MD; Dip. HIV Man; MSc (Epidemiology). IAS 2017, Paris, France. STUDY TEAM: . Rhoderick Machekano. 1. , . In the Classroom. January/February 2013 issue . of . Radiologic . Technology. Instructions:. This presentation provides a framework for educators and students to use Directed Reading content published in . Drew Lambert, . PharmD. lambertd@husson.edu. Husson University School of Pharmacy. 1. I have no conflicts of interest.. However, I will be using brand names extensively during the presentation. Majority of the drugs used are brand-only. HIV Cure Research Training Curriculum. Pediatric HIV Cure module by: Kaitlin Rainwater-Lovett, PhD, MPH, . Priyanka. . Uprety. , and Deborah Persaud, MD. Johns Hopkins University. . Martha . Jeffrey B. Joy, Richard H. Liang, Rosemary M. McCloskey, Thuy Nguyen, Chanson J. Brumme, Guillaume Colley, Robert S. Hogg, Julio S.G. Montaner, P. Richard Harrigan, and Art F.Y. Poon. Conflict of Interest. (PMTCT). What is PMTCT?. The . transmission of HIV from an HIV-positive mother to her child during pregnancy, . labor. , delivery or breastfeeding is called mother-to-child . transmission (MTCT). . WHO 2011. اختصاصي الامراض الباطنة . البورد العربي . كلية طب الموصل . . 2013. Short-Course Antiretroviral Therapy in Primary HIV Infection. HIV1 and slower to progress to AIDS.. Most cases are due to type1.. Modes of transmission. 1-sexual.. 2- perinatal.. 3-parenteral(occupational and intravenous drug injection).. 4- blood transfusion.. ​). Bhaveen Kalidas. ​. Daniel . Tharratt. Introduction. Vertical transmission. Vast majority of infections. P. erinatal morbidity and mortality.. PMTCT. What does it entail?. Statistics:. 15% to 45% without treatment.

Download Document

Here is the link to download the presentation.
"PHARMACOGENETICS OF ANTIRETROVIRAL DRUGS USED FOR PREVENTION OF MOTHER-TO-CHILD TRANSMISSION"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Documents